Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)ANDA217830-003

ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE(ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE)

Manufacturer: MACLEODS PHARMACEUTICALS LTD

FDA Approval: 17/09/2025

Active Ingredients

ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE 30MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.